PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis |
| Symptom | C0239946|liver fibrosis |
| Sentences | 187 |
| PubMedID- 24581967 | Aim: to evaluate whether the relative apparent diffusion coefficient (radc) can help determine the stage of liver fibrosis in patients with chronic hepatitis b virus (hbv) by using the spleen and renal cortex as reference organs. |
| PubMedID- 22087126 | The apri was calculated as (ast level/upper normal limit for ast)/platelet counts (109/l) × 100. the stage of liver fibrosis in patients with chronic viral hepatitis was graded using the metavir scale. |
| PubMedID- 23405210 | Accurate assessment of the severity of liver fibrosis in patients with chronic hepatitis b (chb) is necessary not only to predict the long-term clinical course, but also to determine whether and when to begin antiviral therapy. |
| PubMedID- 26180854 with Chronic Hepatitis B and C: A Review of Diagnostic Accuracy, Clinical Effectiveness, Cost-Effectiveness and Guidelines | This report represents a pseudo update to a previous 2012 report that reviewed the clinical and cost-effectiveness evidence of diagnosis and monitoring of liver fibrosis among patients with chronic hepatitis c. |
| PubMedID- 20698740 | liver fibrosis in hepatitis c patients of pakistani versus scandinavian origin. |
| PubMedID- 22235211 | Noninvasive evaluation of liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 22254137 | Validation of hepascore as a predictor of liver fibrosis in patients with chronic hepatitis c infection. |
| PubMedID- 23445460 | We designed a non-invasive method, called magnetic resonance laparoscopy (mrl), based on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging, to assess liver fibrosis in patients with chronic hepatitis b and c virus. |
| PubMedID- 22125159 | Most hcv infections persist, with up to 80% of all cases leading to chronic hepatitis associated with liver fibrosis, cirrhosis, and hepatocellular carcinoma. |
| PubMedID- 26245999 | Presented approach is used to recognize liver fibrosis stage of patients with hepatitis c virus (hcv) infection. |
| PubMedID- 23431353 | Additionally, a multicenter, randomized, double-blinded, and parallel control experiment demonstrated that fzhy had good therapeutic effects on improving liver fibrosis due to chronic hepatitis b . |
| PubMedID- 22497817 | End-stage renal disease and african american race are independent predictors of mild liver fibrosis in patients with chronic hepatitis c infection. |
| PubMedID- 26402972 | Hepatic necroinflammation and severe liver fibrosis in patients with chronic hepatitis b with undetectable hbv dna and persistently normal alanine aminotransferase. |
| PubMedID- 25548740 | Conclusions: serum transferrin could be promising serum marker for predicting advanced liver fibrosis in patients with chronic hepatitis b. |
| PubMedID- 26448760 | Similarly, phase ii trials of a human monoclonal antibody for ctgf (fg 3019) for patients with liver fibrosis (due to chronic hepatitis b infection) and pulmonary fibrosis are promising. |
| PubMedID- 24612251 | Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis b--a prospective cohort study with paired transient elastography examinations. |
| PubMedID- 19709360 | T-helper cells and liver fibrosis in hepatitis c virus-monoinfected patients. |
| PubMedID- 24631902 | The aim of this study was to describe the diagnostic performance of fibrotest(r), fibrometer(r), and hepascore(r) for liver fibrosis in hepatitis b compared to hepatitis c. |
| PubMedID- 22176964 | Objective: to evaluate the value of transient elastography (te) for predicting severity of liver fibrosis in patients with chronic hepatitis b (chb). |
| PubMedID- 23910059 | Conclusion: use of ecstasy and cocaine may cause chronic hepatitis leading to marked liver fibrosis, which may regress after withdrawal of both substances. |
| PubMedID- 24735138 | Commentary: coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis b - authors' reply. |
| PubMedID- 22783349 | In most of the published studies these serum markers panels were used in order to assess liver fibrosis in patients with chronic hepatitis, particularly chronic hepatitis c. simultaneously it is recommended that combination of these markers done in other types of liver fibrosis diseases including chronic hepatitis b, autoimmune hepatitis, non-alcoholic fatty liver disease and the others. |
| PubMedID- 22698510 | Comparative study concerning the value of acoustic radiation force impulse elastography (arfi) in comparison with transient elastography (te) for the assessment of liver fibrosis in patients with chronic hepatitis b and c. |
| PubMedID- 22959098 | Performances of elasto-fibrotest((r)), a combination between fibrotest((r)) and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 22796373 | Comparison of lect-hepa and fibroscan for assessment of liver fibrosis in hepatitis b virus infected patients with different alt levels. |
| PubMedID- 22070853 | Single stage and multistage classification models for the prediction of liver fibrosis degree in patients with chronic hepatitis c infection. |
| PubMedID- 25966326 | Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis b. |
| PubMedID- 21235598 | Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis b carriers. |
| PubMedID- 21889468 | Relative performances of fibrotest, fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis c: a step toward the truth in the absence of a gold standard. |
| PubMedID- 21971536 | Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 23301544 | Serum bile acid levels as a predictor for the severity of liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 26391629 | A novel non-invasive index using afp and aptt is associated with liver fibrosis in patients with chronic hepatitis b infection: a retrospective cohort study. |
| PubMedID- 23724041 | The natural history of liver fibrosis progression in patients with chronic hepatitis b (hbv) or c virus (hcv) infection is highly variable and depends on both host and viral factors 1. |
| PubMedID- 20665624 | Validation of noninvasive methods for the assessment of liver fibrosis in patients with recurrent hepatitis c after transplantation. |
| PubMedID- 24489961 | Most hcv infections persist, with up to 80% of all cases leading to chronic hepatitis associated with liver fibrosis, liver cirrhosis (lc) and hepatocellular carcinoma (hcc) . |
| PubMedID- 22035045 | Conclusions: safe biopsy and the fibropaca algorithm have excellent performance for liver fibrosis in hepatitis c, allowing a significant reduction in the need for liver biopsies. |
| PubMedID- 22675458 | Clinical trials are currently underway using a fully human igg1κ monoclonal antibody that recognizes domain 2 of human and rodent ctgf (this monoclonal is called fg-3019 and was developed by fibrogen, inc., south san francisco, ca) as a novel therapy to treat patients with pancreatic cancer, idiopathic pulmonary fibrosis, and liver fibrosis due to chronic hepatitis b infection . |
| PubMedID- 21931759 | Progressive liver fibrosis due to chronic viral hepatitis, autoimmune, metabolic or hereditary disorders is a leading cause of morbidity and mortality in the western world (reviewed in , 3). |
| PubMedID- 23222845 | Despite a generally asymptomatic course of hcv infection in children with mild histological changes in the liver, chronic hepatitis c may lead to liver fibrosis, cirrhosis, and even hcc in children and adolescents . |
| PubMedID- 23112543 | Liver biopsy (lb) has traditionally been considered the gold standard for pretreatment evaluation of liver fibrosis in patients with chronic hepatitis c (chc). |
| PubMedID- 26356792 | The performance of fibroscan® (echosens, paris, france) in particular has been widely validated in the assessment of liver fibrosis in patients with chronic hepatitis c virus infection, leading to further studies evaluating its utility in ald. |
| PubMedID- 21507271 | Background: hepatitis c can lead to liver fibrosis and cirrhosis. |
| PubMedID- 24237300 | In conclusion, at 500 iu/day, oral interferon exerted a borderline suppression effect of virological relapse in chronic hepatitis c patients with mild liver fibrosis. |
| PubMedID- 23845056 | Regulation of tsp-1 with regards to its influence on tgf-β1 activity may be one of the causes of fibrosis, as tgf-β1 positively regulates hcv rna replication which is likely manifested in the liver fibrosis associated with hepatitis c infection . |
| PubMedID- 22761744 | Further, ip-10 assays have also shown promise for liver fibrosis monitoring in patients with chronic hepatitis c viral infection (hcv) . |
| PubMedID- 25788955 | Assessment of liver fibrosis in patients with chronic hepatitis c is useful to decide the optimal timing of antiviral therapy. |
| PubMedID- 22848675 | Accurate assessment of the severity of liver fibrosis in patients with chronic hepatitis b (chb) is necessary for not only prediction of the long-term clinical course, but also determination of whether and when to begin antiviral therapy. |
| PubMedID- 26017074 | Association of caffeine intake and liver fibrosis in patients with chronic hepatitis c. |
| PubMedID- 24957386 | Comparison of ai techniques for prediction of liver fibrosis in hepatitis patients. |
| PubMedID- 22613424 | Clinical utility of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 concentrations in the assessment of liver fibrosis due to chronic hepatitis b. |